Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancer

Frontiers in Oncology(2022)10.3389/fonc.2022.1018767Source: DataRank Database

Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancer is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.84)OA: goldTopics (29)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Peter John,Tyler Friedman,Jeeshan Jiffry,Hillary Guzik ORCID,Rifat Mannan ORCID

Live enrichment

PubMed:36387154 PMC:PMC9642964 OpenAlex:https://openalex.org/W4307244874

National Institutes of Health

Grant: 1R21AG058027-01

COMPARATIVE EFFECTIVENESS OF BIOLOGIC AGENTS IN ETHNIC MINORITIES WITH COLORECTAL CANCER

National Institutes of Health

Grant: 1S10OD019961-01

High-speed/resolution whole slide scanner supported by two core facilities

National Institutes of Health

Grant: 3P30CA013330-39S3

Core Support for Cancer Center

FWCI

0.84

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fonc.2022.1018767/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2022.1018767/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2022.1018767/full

journalhttps://doi.org/10.3389/fonc.2022.1018767

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36387154

Fields of Study

Cancer Immunotherapy and BiomarkersVirus-based gene therapy researchCancer Research and Treatments0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Oncolytic virusImmune systemCancer researchImmune checkpointColorectal cancerInnate immune systemBiologyMicrosatellite instabilityImmunotherapyT cellCancerImmunologyMicrosatelliteGeneticsreovirusTranslationalCombinatorial TherapyAnti-pd-1570610Neoplasms. Tumors. Oncology. Including cancer and carcinogensOncologyRC254-282

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being